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Abstract
The xenotropic murine leukemia virus (MLV)-related viruses (XMRV) have been reported in persons with prostate cancer,
chronic fatigue syndrome, and less frequently in blood donors. Polytropic MLVs have also been described in persons with
CFS and blood donors. However, many studies have failed to confirm these findings, raising the possibility of contamination
as a source of the positive results. One PCR reagent, Platinum Taq polymerase (pol) has been reported to contain mouse
DNA that produces false-positive MLV PCR results. We report here the finding of a large number of PCR reagents that have
low levels of MLV sequences. We found that recombinant reverse-transcriptase (RT) enzymes from six companies derived
from either MLV or avian myeloblastosis virus contained MLV pol DNA sequences but not gag or mouse DNA sequences.
Sequence and phylogenetic analysis showed high relatedness to Moloney MLV, suggesting residual contamination with an
RT-containing plasmid. In addition, we identified contamination with mouse DNA and a variety of MLV sequences in
commercially available human DNAs from leukocytes, brain tissues, and cell lines. These results identify new sources of MLV
contamination and highlight the importance of careful pre-screening of commercial specimens and diagnostic reagents to
avoid false-positive MLV PCR results.
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Introduction
Xenotropic murine leukemia virus (MLV)-related virus
(XMRV) is a new gammaretrovirus reported in persons from the
U.S. with prostate cancer or chronic fatigue syndrome (CFS), and
in blood donors [1]. MLV-like sequences have also been found in
specimens from persons with CFS from the US [2]. However,
numerous studies using both PCR and serology, both in the U.S.
and abroad, were unable to replicate these findings, stimulating
much debate and discussion regarding the origin of the positive
results seen in the initial studies [3,4,5,6,7,8,9,10,11,12,13,14].
MLVs are endogenous and exogenous retroviruses whose
genomes are integrated into mouse chromosomal DNA and can
thus be PCR-amplified along with other mouse-specific sequences
in specimens contaminated with mouse DNA. Several groups have
shown recently that Platinum Taq polymerase from Invitrogen, or
reverse transcriptase (RT)-PCR kits containing this enzyme,
contain low levels of mouse DNA that produce a positive PCR
signal with diagnostic XMRV or MLV primers [1,4,15,16,17].
The contamination source in Platinum Taq from these studies was
linked to carry-over mouse DNA from the mouse monoclonal
antibody used to keep Taq inactive during hot-start PCR. XMRV,
MLV, and murine sequences have also been found recently in
Qiagen nucleic acid extraction columns [18]. High levels of
infectious MLV and XMRV have also been found in human cell
lines [19,20,21]. These results suggest multiple sources of potential
contamination of clinical specimens from different cohorts
[4,19,21,22,23,24].
We report here the identification of widespread MLV
contamination of RT enzymes from six manufacturers as well as
mouse DNA contamination of commercially available human cell
lines and clinical specimens. Our results highlight the importance
of careful pre-screening of diagnostic reagents and commercially
available specimens to avoid false-positive PCR results during
testing of human clinical specimens.
Results
Contamination of commercial RT enzymes with MLV
plasmid DNA
While investigating the prevalence of XMRV and MLV in
persons with CFS and prostate cancer we occasionally detected
low levels (,10 copies) MLV and XMRV-like protease (pro)
sequences in non-template controls (NTC) or negative blood
donor plasma by using a quantitative RT-PCR (qRT-PCR) assay
that employs the ABI/Ambion AgPath One Step RT-PCR kit
(Cat# 4387391, Austin, Tx) [3]. Results for clinical specimens in
runs with false-positive negative controls were always considered
invalid and were repeated. None of the pro sequences detected in
the NTC and negative blood donor samples contained the
signature sequence present in the positive control template
engineered in our laboratory, indicating that the qPCR standard
template was not the source of the pro signals (data not shown).
The recombinant RT enzyme used in the pro qRT-PCR testing
was included in the ABI/Ambion AgPath One Step RT-PCR kit
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and according to the manufacturer was derived from an
expression plasmid containing the ecotropic Moloney MLV
(MoMLV) RT gene. The reagents in this kit are different from
those in the Invitrogen One-step RT-PCR kit or Taq enzymes
previously found to be contaminated with mouse DNA [1,4,15,17]
in that they do not contain mouse monoclonal antibodies to keep
the Taq inactive during hot start PCR.
Given the plasmid production history of this enzyme and
absence of mouse monoclonal antibodies in the reagents, we
suspected that the AgPath RT-PCR kit was contaminated with
trace amounts of residual MLV-like plasmid sequences. Further-
more, the enzyme was repeatedly negative for mouse DNA
contamination using highly sensitive PCR tests for mitochondrial
(mtDNA) and intracisternal A particle (IAP) DNA sequences that
can detect attograms of mouse DNA (Table 1) [3]. To evaluate this
hypothesis further, we tested multiple replicates of NTC in the pro
qRT-PCR test. Low levels (Table 1, 1–10 copies/reaction) of
MLV/XMRV were found in 7 of 16 replicates in a new,
previously un-opened AgPath one step RT-PCR kit. All 16 water-
only reactions without the RT enzyme were negative. The
proportion of positive NTCs was similar when a larger number of
NTC replicates was tested (13/32), but increased significantly
when the amount of enzyme was doubled (15/16 positives). Four
of five different kit lots tested positive in the pro qPCR assay at a
frequency ranging from 1/16 to 7/16 replicates when using 1 ul of
enzyme per reaction (Table 1). Representative pro qPCR results
are shown in Fig. 1a. These results document frequent
contamination of different lots of this enzyme with low levels of
MLV sequences.
To confirm the contaminant was from a DNA source, we added
the AgPath enzyme into a qPCR pro DNA PCR test using an
AmpliTaq Gold enzyme (Cat # N8080244; ABI, Foster City,
CA), previously determined to be free of any MLV/XMRV, and
amplified using the same conditions used for the pro qRT-PCR test
except the first step included a 9 min 95uC step to inactivate the
AgPath RT. 7/16 (44%) NTC reactions tested positive (Table 1).
The AgPath enzyme was found to be negative for gag sequences
(0/16), but positive for pol sequences (14/16, 88%) using two new
qRT-PCR tests to generically detect MLV and XMRV (Table 1).
To investigate the breadth of this contamination in other RT
enzymes and kits, we tested both MoMLV- and avian myeloblas-
tosis virus (AMV)-derived recombinant RTs from multiple
manufacturers using the pro qRT-PCR test or a nested polymerase
(pol) RT-PCR test that generically detects MLV and XMRV
sequences about 216-bp in length using the primers XPOLOF,
XPOLOR, XPOLIF, and XPOLOR [5,9]. AMV and MLV are
highly divergent retroviruses in different genera sharing only 28%
pol nucleotide identity and thus the MLV-based primers and
probes should not amplify AMV sequences if present. We found
that two MoMLV-based RT kits from ABI (TaqMan 1-step
Master Mix and TaqMan RNA to Ct kit; cat #s 43019169 and
432938, respectively, Foster City, CA) and one MoMLV-based kit
from Agilent (Brilliant II QRT-PCR Master mix; cat # 600884;
Santa Clara, CA) contained low copies of XMRV/MLV
sequences in 4/16 (25%)–6/16 (38%) replicates, respectively
(Table 1). Likewise, a Roche (Transcriptor 1-step RT-PCR kit; cat
# 04655877001; Indianapolis, IN) and a Finnzymes kit (RobusT I
RT-PCR kit; cat# F580L; Thermo Fisher Scientific, Lafayette,
CO) that both include AMV RT were also positive for XMRV/
MLV pro (8/16 (50%)) and pol sequences (4/16 (25%) and 2/16
(13%), respectively (Table 1). The Finnzymes kit failed to amplify
sequences from the standard controls using the pro qRT-PCR
primers and probes. Thus, the nested pol PCR assay was used to
test the RT in the Finnzymes kit. Fig. 1b shows the detection of pol
sequences in 2/16 (12.5%) replicates in the AMV RT from
Finnzymes. Increasing amounts of AMV RT from the Finnzymes
kit used in the nested pol PCR test also yielded increasing
quantities of detectable contaminants (5/16, 31%). We also
replaced the AMV RT from Finnzymes with an AMV RT from
Promega and repeated the testing and found no positive reactions
Table 1. Contamination of commercial RT-PCR reagents with murine leukemia virus (MLV).1









ABI/Ambion AgPath One Step RT-PCR kit MoMLV 1009030 7/16 (44, 1–10) 0/16 6/16 (38) 0/16 0/16
AgPath One Step RT-PCR kit MoMLV 909020 1/16 (6, 1–10) ND3 ND ND ND
AgPath One Step RT-PCR kit MoMLV 1009025 2/16 (13, 1–10) ND ND ND ND
AgPath One Step RT-PCR kit MoMLV 1003027 0/16 ND ND ND ND
AgPath One Step RT-PCR kit MoMLV 1010031 2/16 (13, 1–10) ND ND ND ND
ABI AmpliTaq+AgPath enzyme MoMLV 1009030 7/16 (44, 1–10) ND ND ND ND
ABI TaqMan 1-Step Master mix MoMLV 1006001 4/16 (25, 1–10) 0/16 12/16 (75) 0/16 0/16
ABI TaqMan RNA to CT kit MoMLV 802002 4/16 (25, 1–10) ND ND ND ND
Agilent Brilliant II QRT-PCR Master mix MoMLV 6080963 6/16 (38, 1–10) 0/16 15/16 (94) 0/16 0/16
Promega Access RT-PCR system AMV 316238 0/16 ND ND ND ND
AccessQuick RT-PCR system AMV 313296 0/16 0/16 0/16 0/16 0/16
AccessQuick RT-PCR system AMV 316238 0/16 ND ND ND ND
Roche Transcriptor 1-step RT-PCR kit AMV 12275200 8/16 (50, 1–10) 0/16 4/16 (25) 0/16 0/16
Transcriptor 1-step RT-PCR kit AMV 12513300 2/16 (13, 1–10) ND ND ND ND
Finnzymes RobusT I RT-PCR kit AMV 127 failed 0/16 2/16 (13) 0/16 0/16
1The reverse transcriptase (RT) enzymes and kits were tested by quantitative protease (pro), polymerase (pol), gag and/or nested pol RT-PCR assays and results shown
are number of positive tests out of the total number of replicates. Percentages for replicate testing and copies/reaction (rxn) are in parentheses.
2Mouse DNA contamination was detected using mitochondrial DNA (mtDNA) and intracisternal A particle (IAP) PCR qPCR assays.
3ND, not done.
doi:10.1371/journal.pone.0029050.t001
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in the water only controls (0/16, data not shown), further
supporting the contamination of the Finnzymes RT. In contrast,
AMV RTs in two kits from Promega (Access RT-PCR (cat#
A1259) and AccessQuick RT-PCR (cat# A1702) systems,
Madison, WI) were both negative in all 16 replicates (Table 1).
None of the enzymes with detectable MLV sequences were
positive for mouse mtDNA or IAP sequences in any of the 16
replicates. These results suggest that the source of the MLV
sequences in these enzymes is not mouse DNA.
To infer the origin of the contaminants we performed
phylogenetic analysis of pol sequences from multiple clones from
the PCR-positive RT enzymes and kits, multiple prototypic MLV
pol sequences, and those identified with the highest homology by
BLAST analysis using the Neighbor joining distance-based
method. The pol sequences found in the RT enzymes shared
.99% identity with MoMLV (GenBank accession number
J02255). Phylogenetic analysis of 168-bp pol sequences showed
that the RTs and RT kits have MLV-like sequences genetically
related to MoMLV that are distinct from XMRV (Fig. 2). The
absence of detectable gag sequences in the contaminated RT
reagents is consistent with a provenance from a plasmid containing
only pol sequences. As previously reported, the pol sequences did
not cluster by virus host cell tropism, reflective of a probable
history of recombination occurring in this region [3].
Figure 1. Contamination of commercial AMV reverse transcriptases (RT) with MLV sequences. A. Representative real-time, generic MLV
protease (pro) amplification plot. Blue lines, XMRV RNA standard extracted from 22Rv1 cell culture supernatants from 106–100 copies per reaction;
burgundy lines with triangles, 4/16 (25%) water only controls tested positive for MLV pro sequences using the ABI TaqMan Fast 1-step Master Mix;
bright green line, RFU, relative fluorescent units. B. Representative gel image showing nested PCR detection of 208-bp MLV polymerase (pol)
sequences in water only control reactions using Finnzymes RobustI AMV RT. Lanes 1–16, water only controls; lanes 17–20, XMRV RNA extracted from
22Rv1 cell culture supernatants from 103, 102, and 10 copies per reaction, respectively; M. molecular weight marker.
doi:10.1371/journal.pone.0029050.g001
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Figure 2. Inference of contamination origin in commercial RT-PCR reagents and human genomic DNAs. Phylogenetic analysis of 168-bp
polymerase (pol) sequences. Bootstrap values $60 are shown. New sequences from the current study are shown in red (RT contaminants) and blue
(human genomic DNA contaminants). Sequence names in purple are those reported as contaminants from other human studies. GenBank accession
numbers for prototypical murine leukemia virus (MLV) reference sequences are provided in parentheses. XMRV clades are collapsed for presentation
only and include identical sequences from CFS-WPI-1106(GQ497344), CFS-WPI-1178(GQ497343), preXMRV2(FR871850), PC-VP35(DQ241301), PC-
VP42(DQ241302), PC-VP62(DQ399707), 22Rv1/CWR-R1(FN692043) The 168-bp pol sequences are available from the authors upon request. GenBank
does not accept sequences less than 200-bp in length. Sequences coded as XMRV VP and WPI are from prostate cancer (PC) and CFS patients,
respectively. BD; blood donor sequences. Viral host receptor tropism is indicated by blue (xenotropic), purple (polytropic), and yellow (ecotropic)
spheres. PMLV, polytropic MLV; XMLV, xenotropic MLV.
doi:10.1371/journal.pone.0029050.g002
Detection of MLV in RT-PCR Reagents and Human DNAs
PLoS ONE | www.plosone.org 4 December 2011 | Volume 6 | Issue 12 | e29050
Contamination of commercial human DNAs with mouse
DNA
We also found that commercially available DNAs are
contaminated with mouse DNA. Commercially prepared human
cell line and tissue DNAs were purchased for use as negative
controls in our PCR assays from Sigma-Aldrich (St. Louis, MO)
and Biochain (Hayward, CA). All ten Biochain human specimens,
including DNA from leukocytes, the B- and T-cell lines Raji and
Jurkat, respectively, two tumor cell lines (K562 and MCF-7) and
four DNAs from brain tissues of persons with neurologic disorders
(dementia, Alzheimer’s, Parkinson’s, and multiple sclerosis) were
positive for XMRV/MLV pro, and pol sequences, and mouse IAP
and mtDNA sequences (Table 2). In addition, all of the Biochain
DNAs contained MLV gag sequences (Table 2). Although most of
the Biochain specimens showed low levels of contamination, the
leukocyte DNA had significant amounts of contamination with
,8,000 copies/mg pro, 39,200 copies/mg IAP, and 232,000
copies/mg mouse mtDNA sequences detected (Table 2, Fig. 3).
Although the assays showed the same level of sensitivity using
plasmid standards, differences in the amounts of mouse mtDNA
versus IAP sequences were detected in some DNA samples and
can be explained as pipetting errors or due to increased expression
of mtDNA in some cells compared to the stability of integrated
IAP sequences. Similar discordant levels of mtDNA and IAP
sequences have been reported previously in patient samples
contaminated with mouse DNA [22].
Analysis of the 168-bp pol sequences confirmed mouse DNA
contamination of the samples with the majority (6/7, 86%)
showing 98–100% nucleotide identity to an endogenous retrovi-
rus present on mouse chromosome 12 (GenBank accession #
CT030142). The pol sequence detected in the MS brain tissue
DNA had 99% nucleotide identity to a xenotropic MLV
(XMLV15, Genbank accession # HQ154630). In contrast, two
human placental DNAs from Sigma-Aldrich both tested negative
for XMRV/MLV and mouse IAP and mtDNA sequences
(Table 2). Phylogenetic analysis of 168-bp pol sequences obtained
from the Biochain samples inferred genetic relatedness across the
diversity of MLV by clustering with different xenotropic and
polytropic MLVs, but which were all distinct from XMRV
(Fig. 2).
Likewise, phylogenetic analysis of an alignment of 301-bp gag
sequences showed that those obtained from the Biochain DNAs
were divergent from XMRV and clustered with various
xenotropic and polytropic MLVs (Fig. 4). These results are
consistent with the genetic diversity of endogenous MLVs in the
mouse genome. Interestingly, we also observed the same level of
diversity in PMLV sequences identified in CFS patients and blood
donors, and in other human specimens and cell lines, congruent
with an external mouse cell or DNA contamination source (Fig. 4)
[2,17,20,25,26]. Biochain was notified of these results and
independently confirmed the presence of mouse mtDNA sequenc-
es in the human leukocyte DNA. After implementing measures to
prevent carry-over contamination of human DNAs with mouse
material also processed at their facility, a new lot of human
leukocyte DNA (B210149) tested negative for mouse mtDNA
sequences at Biochain, and MLV sequences at CDC, but was still
weakly positive for IAP and mtDNA sequences (1–10 copies/rxn)
at CDC (Table 2).
Discussion
Our results show the frequent contamination of commercial RT
enzymes and RT-PCR kits with residual pol sequences that are
highly related to MoMLV. The absence of detectable MLV gag
and mouse DNA sequences suggest that the most likely source of
the contamination is an expression plasmid vector containing only
MoMLV pro and pol sequences. These results are consistent with
patented MoMLV RT-expression vectors that consist of only
partial pro and 59 RT sequences. The RNase H and integrase
regions of the MoMLV pol in this expression vector were
selectively removed. The low-level contamination most likely
reflects the difficulty in completely removing plasmid DNA with
DNase treatment following protein expression. Our data also show
that the same MLV sequences are present in AMV RTs,
suggesting that the source of contamination of this reagent is not
the AMV plasmid but likely carry-over contamination with the
MLV RT-containing plasmid. It is possible that such contamina-
Table 2. Contamination of commercial human DNAs with mouse DNA.1
Manufacturer DNA Specimen Lot no. pro (copies/rxn) gag pol mtDNA2 (copies/mg) IAP2 (copies/mg)
Biochain Human leukocyte DNA A807119 8,000 Pos Pos 232,000 39,200
Human leukocyte DNA3 B210149 Neg Neg Neg 1–10 1–10
Dementia DNA B409046 10 Pos Pos 46 120
Parkinson’s DNA B303007 1–10 Pos Pos 1430 877
Alzheimer’s DNA B111073 10–20 Pos Pos 6 1120
Multiple sclerosis DNA B409045 1–10 Pos Pos 52 16
Raji DNA NA4 Neg Pos Pos 58 10–20
Jurkat DNA NA Neg Pos Pos 2 10–20
K562 DNA NA Neg ND Neg 6 Neg
MCF-7 DNA NA Neg ND Neg Neg 10–20
Sigma-Aldrich Male placental DNA 88F3847 Neg Neg Neg Neg Neg
Female placental DNA NA Neg Neg Neg Neg Neg
11 ug of the human DNAs were tested using quantitative (qPCR) pro and nested pol and gag PCR assays. Copies/mg DNA is provided in parentheses for specimens with
evidence of contamination.
2Mouse DNA contamination was detected using mitochondrial DNA (mtDNA) and intracisternal A particle (IAP) PCR qPCR assays.
3Second lot of human DNA sample received from Biochain after informing them of the contamination results.
4NA, information not available.
doi:10.1371/journal.pone.0029050.t002
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Figure 3. Contamination of commercial human genomic DNA specimens with mouse DNA. A. Representative real-time, generic mouse
mitochondrial DNA and B. intracisternal A particle (IAP) polymerase (pol) amplification plots. Blue lines, mouse mtDNA or IAP plasmid DNA from 106–100 and
107–101 copies per reaction, respectively; burgundy lines with triangles, human genomic DNA extracted from brain tissue of persons with various inflammatory
diseases and two aliquots of the same lot of human peripheral blood lymphocytes (PBL); bright green line, RFU, relative fluorescent units. IAP and mtDNA assay
are sensitive to at least 10 copies per reaction.
doi:10.1371/journal.pone.0029050.g003
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tion can occur during production of both AMV and MLV RTs in
the same laboratories. Although we showed that currently used
diagnostic PCR can detect this MLV sequence, the phylogenetic
analysis was important to demonstrate that the sequences are
highly related to MoMLV, an ecotropic virus that cannot infect
human cells, and would thus indicate contamination if found in a
human specimen. Our data therefore re-iterate the importance of
phylogenetic analysis for all specimens testing PCR-positive
[19,27].
We also demonstrate that commercially prepared human DNAs
from a variety of clinical specimens and cell lines can be
contaminated with mouse DNA likely originating from mouse
tissue processing in the same facility. Unlike the situation observed
for the RT kits, we showed that the level of contamination of these
specimens can be high and, thus, easy to detect by assays for
mouse or MLV DNA. Our findings should serve to remind
commercial providers to institute measures to prevent cross-
contamination.
Conclusions
Combined, our results show that MLV and mouse DNA
contamination is more widespread in diagnostic reagents and
clinical specimens than previously thought. These data reinforce
the need for rigorous screening of all diagnostic reagents and
specimens by methods capable of detecting trace amounts of MLV
and mouse DNA, and to use phylogenetic analysis to assess the
biological significance of newly detected sequences. Also, since
many of the contaminated RT and PCR reagents are widely used
in metagenomics studies, our data call for careful interpretation of
any murine retroviral sequences that are detected in these
analyses.
Materials and Methods
RT-PCR kits and human DNAs
The manufacturer and lot numbers of the nine RT-PCR kits
tested in our study are listed in Table 1. Nine human DNAs from
either disease tissues or cell lines were purchased from Biochain
(Hayward, CA), while the male and female placental DNAs were
obtained from Sigma-Aldrich (St. Louis, MO) (Table 2).
PCR testing for MLVs and mouse sequences
The pro qRT-PCR assay was used to screen specimens and
reagents for evidence of MLV/XMRV contamination since it
generically detects all MLVs and XMRV [3]. This assay uses the
Taqman primers Pro-UNV-F1 (59 CCT GAA CCC AGG ATA
ACC CT 39) and Pro-UNV-R1 (59 GTG GTC CAG CGA TAC
CGC T 39) and probes Pro-UNV-P1C (FAM59 AGA TAC TGG
GGC CCA ACA CTC CGT GCT GAC 39BHQ1) and Pro-
UNV-PR1 (FAM59 CCT CCA GTA GCC CCT TGG ACC
CAG GC 39BHQ1) in a one-step RT-PCR reaction mixture at
45uC for 20 min, 95uC for 10 min, followed by 55 cycles of 95uC
for 30 sec, 52uC for 30 sec and 62uC for 30 sec. We also use an
engineered standard template for quantification of pro sequences
that contains two unique nine-bp nucleotide insertions that code
for the amino acids methionine-leucine-valine (MLV)and trypto-
phan-methionine-threonine (WMT) separated by a 31-bp hamster
gammaretrovirus sequence that are not present in wild-type MLV
pro sequences [28].
To further evaluate the origin of the MLV sequences detected
in the RT reagents and human DNAs we also used three
additional PCR tests targeting the gag and pol regions of the MLV
and XMRV genomes. For the gag qRT-PCR assay, the primers
GAG-UNV-F1, 59AGGTAGGAACCACCTAGTYC and GAG-
UNV-R1, 59GTCCTCAGGGTCATAAGGAG and probes GA-
G-UNV-P1C, 59FAM AGCGGGTCTCCAAAACGCGGGC 39B-
HQ1 and GAG-UNV-PR1, 59FAM CCTTTTACCTTGGCCA-
AATTGGTGGG 39BHQ1 were used [5]. For the pol qRT-PCR
Figure 4. Inference of contamination origin in commercial
human genomic DNAs. Phylogenetic analysis of 301-bp gag
sequences. Bootstrap values $60 are shown. New sequences from
the current study are shown in blue (human genomic DNA
contaminants). Sequence names in purple are those reported as
contaminants from other human studies. GenBank accession numbers
for prototypical murine leukemia virus (MLV) reference sequences are
provided in parentheses. XMRV clades are collapsed for presentation
only and include CFS-WPI-1106(GQ497344), CFS-WPI-1178(GQ497343),
CFS-WPI-1130(GQ483508), CFS-WPI-1138(GQ483509), CFS-WPI-
1169(GQ483510), CFS-WPI-CI-1303(JF907633) , CFS-WPI-CI-
1313(JF907643), CFS-WPI-CI-1314T(JF907644) , CFS-WPI-CI-
1307(JF907638) , CFS-WPI -CI -1310(JF907641) , CFS-WPI-CI -
1327(JF907636), preXMRV2(FR871850), PC-VP35(DQ241301),and PC-
VP62(DQ399707). Accession numbers for the new gag sequences
generated in our study are JN629081-JN629087. Sequences coded as
XMRV VP and WPI are from prostate cancer (PC) and CFS patients,
respectively. BD; blood donor sequences. Viral host receptor tropism is
indicated by blue (xenotropic), purple (polytropic), and yellow
(ecotropic) spheres. PMLV, polytropic MLV; XMLV, xenotropic MLV.
doi:10.1371/journal.pone.0029050.g004
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test, the primers POL-UNV-F1 59CAGAGATGGCTGACTGAG-
GC39 and POL-UNV-R1 59AAACAGAGTCC CCGTTTTG-
GT39 and probes POL-UNV-P1C 59FAM AGGGAGTTCCTA-
GGGACGGCAGGCTTCT 39BHQ1 and POL-UNV-PR1C
59FAM CAAACCCAGGGATCCAGAGGCGACAG 39BHQ1
were used. Both assays used the same conditions as the pro qRT-
PCR test and gave sensitivities similar to the pro qRT-PCR test
detecting 1–10 copies MLV/XMRV per reaction (data not shown).
We also used a nested polymerase (pol) RT-PCR test that generically
detects MLV and XMRV sequences about 216-bp in length using
the primers XPOLOF and XPOLOR, and XPOLIF and
XPOLOR [5,9].
For detection of mouse mtDNA, the primers MCOX2F2 (59
TTC TAC CAG CTG TAA TCC TTA 39) and MCOX2R1 (59
GTT TTA GGT CGT TTG TTG GGA T 39) and probes
MCOX2PR1 (59 FAM-CGT AGC TTC AGT ATC ATT GGT
GCC CTA TGG T-BHQ 39) and MCOX2P1 (59 FAM-TTG
CTC TCC CCT CTC TAC GCA TTC TA-BHQ 39) were used
in a two-step thermocycling of 95uC for 30 sec and 62uC 30 sec
for 55 cycles on an iQ5 instrument (Bio-Rad, Hercules, CA).
Dilutions of a plasmid containing murine COX2 sequences that
was generated by PCR with the MCOX2F1 (59 ACA TAC AAG
CAC AAT AGA TGC 39) and MCOX2R1 of the murine
macrophage cell line RAW264.7 (ATCC, Manassas, VI) were
used as the assay standard. For detection of IAP sequences we
developed a new qPCR assays that uses the generic primers and
probes IAP-MH-POLF2: 59 GCCTCAYATGTG ATTCAA-
CATTG 39 and IAP-MH-POLR2: 59 TTGRGASGTATAW-
GCTGGT CCATT 39 and IAP-MH-POL P2: 59 FAM TTG-
AGGCMTGGAGTGCTTGGGGRAAACCCAGA 39BHQ1, re-
spectively. The assay was performed with a hot start at 95uC for
9 min followed by 55 cycles of PCR at 95uC for 30 sec and 62uC
for 30 sec. The PCR product amplified from the murine
macrophage cell line RAW264.7 DNA with the IAP-MH-POLF2
and IAP-MH-POLR2 primers was cloned and used as the assay
standard.
Preparation of RNA standards used in the RT-PCR testing
XMRV pol and gag genes were amplified using the primary PCR
primers, cloned into pCR2.1 TOPO-vectors (Invitrogen), and
transcribed in vitro using the Promega RiboMAX large scale RNA
production system (T7). Following several DNase treatments to
completely remove plasmid DNA, the RNA was quantitated on a
Nanodrop spectrophotometer. Copy number was determined
using the formula (ng RNA6Avogadro constant)/(RNA
length6(16109)6325) and was verified by comparison of qPCR
results using XMRV RNA extracted from 22Rv1 cell culture
supernatant quantitated independently [3].
Sequence analysis
PCR products were purified with QiaQuick PCR or gel
purification kits (Qiagen, Valencia, CA) and were directly
sequenced on both strands by using ABI Prism BigDye terminator
kits and an ABI 31306l sequencer (Foster City, CA) or following
cloning in the TOPO vector (Invitrogen). Initial sequence identity
was determined using BLAST analysis at the National Center for
Biotechnology Information web server (http://blast.ncbi.nlm.nih.
gov/Blast.cgi) using the blastn search option. Sequences were
aligned with those retrieved from the BLAST analysis with the
highest nucleotide identity, and other MLV prototypes available at
GenBank, using MAFFT [29]. Following manual editing and
removal of indels, substitution models and phylogenetic relation-
ships were inferred using the neighbor joining (NJ) method
implemented in MEGA v5.03 [30]. Support for the branching
order was evaluated using 1,000 nonparametric bootstrap
replicates. The 168-bp pol sequences are available from the
authors upon request. GenBank does not accept sequences less
than 200-bp in length. Accession numbers for the new gag
sequences generated in our study are JN629081-JN629087.
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